Artificial intelligence in lung cancer screening: the future is now

M Cellina, LM Cacioppa, M Cè, V Chiarpenello… - Cancers, 2023 - mdpi.com
Simple Summary Lung cancer is a widespread malignant tumour with a high mortality and
morbidity rate and is frequently diagnosed in the middle and late stages when few therapies …

Overdiagnosis of lung cancer with low-dose computed tomography screening: meta-analysis of the randomised clinical trials

J Brodersen, T Voss, F Martiny, V Siersma, A Barratt… - Breathe, 2020 - Eur Respiratory Soc
In low-dose computed tomography (LDCT) screening for lung cancer, all three main
conditions for overdiagnosis in cancer screening are present: 1) a reservoir of slowly or …

Estimation of overdiagnosis of lung cancer in low-dose computed tomography screening: a secondary analysis of the Danish lung cancer screening trial

B Heleno, V Siersma, J Brodersen - JAMA internal medicine, 2018 - jamanetwork.com
Methods| This was an unplanned, post hoc analysis of the DLCST (NCT00496977). 1-3 In
brief, 4104 current or former smokers (≥ 20 pack-years; former smokers must have quit< 10 …

Low-dose CT for lung cancer screening: Position paper from the Italian college of thoracic radiology

M Silva, G Picozzi, N Sverzellati, S Anglesio… - La radiologia …, 2022 - Springer
Smoking is the main risk factor for lung cancer (LC), which is the leading cause of cancer-
related death worldwide. Independent randomized controlled trials, governmental and inter …

Lung cancer screening implementation: complexities and priorities

NM Rankin, A McWilliams, HM Marshall - Respirology, 2020 - Wiley Online Library
Lung cancer is the number one cause of cancer death worldwide. The benefits of lung
cancer screening to reduce mortality and detect early‐stage disease are no longer in any …

Artificial intelligence tools for refining lung cancer screening

JL Espinoza, LT Dong - Journal of clinical medicine, 2020 - mdpi.com
Nearly one-quarter of all cancer deaths worldwide are due to lung cancer, making this
disease the leading cause of cancer death among both men and women. The most …

Systematic review of lung cancer screening: advancements and strategies for implementation

D Amicizia, MF Piazza, F Marchini, M Astengo… - Healthcare, 2023 - mdpi.com
Lung cancer is the leading cause of cancer-related deaths in Europe, with low survival rates
primarily due to late-stage diagnosis. Early detection can significantly improve survival rates …

Baseline results of the West London lung cancer screening pilot study–impact of mobile scanners and dual risk model utilisation

EC Bartlett, SV Kemp, CA Ridge, SR Desai… - Lung Cancer, 2020 - Elsevier
Abstract Objectives The West London lung screening pilot aimed to identify early-stage lung
cancer by targeting low-dose CT (LDCT) to high risk participants. Successful implementation …

Incidental pulmonary nodules–what do we know in 2022

G Schmid-Bindert, J Vogel-Claussen, S Gütz, J Fink… - Respiration, 2022 - karger.com
Lung cancer (LC) is the leading cause of cancer-related mortality worldwide, and early LC
diagnosis can significantly improve outcomes and survival rates in affected patients …

[HTML][HTML] Implementation of lung cancer screening: what are the main issues?

CM van der Aalst, K Ten Haaf… - … Lung Cancer Research, 2021 - ncbi.nlm.nih.gov
Two large-scale RCTs have shown computed tomography (CT) lung cancer screening to be
efficacious in reducing lung cancer mortality (8–24% in men, 26–59% in women). However …